Showcases Stock ranks Forex

Onconova Therapeutic (ONTX)
0.26  -0.006 (-2.26%) 11-27 13:00
Open: 0.2665 Pre. Close: 0.266
High: 0.268 Low: 0.26
Volume: 3,540,492 Market Cap: 48M
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. The company is headquartered in Newtown, Pennsylvania and currently employs 25 full-time employees. The firm operates through the identification and development of oncology therapeutics segment. The company is focused on discovering and developing small molecule drug candidates to treat cancer. The firm has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. The company has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The firm's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 0.27 - 0.272 0.272 - 0.273
Low: 0.257 - 0.258 0.258 - 0.26
Close: 0.268 - 0.27 0.27 - 0.272
Stock Technical Analysis
Target: Six months: 0.32
One year: 0.35
Support: Support1: 0.24
Support2: 0.20
Resistance: Resistance1: 0.28
Resistance2: 0.30
Pivot: 0.27
Moving Averages: MA(5): 0.27
MA(20): 0.26
MA(100): 0.50
MA(250): 0.45
MACD: MACD(12,26): -0.01
Signal(12,26,9): -0.01
%K %D: %K(14,3): 26.67
%D(3): 34.44
RSI: RSI(14): 44.56
52-Week: High: 1.56
Low: 0.19
Change(%): -10.3
Average Vol(K): 3-Month: 1232505
10-Days: 607568
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.

ONTX has closed above bottom band by 31.2%. Bollinger Bands are 91.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to ONTX's normal range. The bands have been in this narrow range for 53 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Sat, 28 Nov 2020
Quarterly Price Performance Soared by -5.04%: Onconova Therapeutics Inc. (NASDAQ:ONTX) - BOV News

Fri, 27 Nov 2020
Is There a Dimmer Outlook Ahead for Onconova Therapeutics Inc. (ONTX)? - The News Heater

Fri, 27 Nov 2020
Time to Buy Beat-Down Onconova Therapeutics Inc. (ONTX) Stock? Here is the INSIGHT - The InvestChronicle

Wed, 25 Nov 2020
Onconova Therapeutics Inc. [ONTX] is -32.40% lower this YTD. Is it still time to buy? - The DBT News

Mon, 23 Nov 2020
Onconova Therapeutics Files Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300 - GlobeNewswire

Sat, 14 Nov 2020
Maxim Group Keeps Their Hold Rating on Onconova Therapeutics (ONTX) - Analyst Ratings

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short Prior Month (K)
Stock Financials
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.) 0.012
Sales Per Share 0.001
EBITDA (p.s.) -0.127
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
PE Ratio
PEG Ratio
Price to Book value
Price to Sales 237.47
Price to Cash Flow
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator